ES2906329T3 - Método de evaluación del potencial de irritación ocular de productos químicos - Google Patents

Método de evaluación del potencial de irritación ocular de productos químicos Download PDF

Info

Publication number
ES2906329T3
ES2906329T3 ES17768146T ES17768146T ES2906329T3 ES 2906329 T3 ES2906329 T3 ES 2906329T3 ES 17768146 T ES17768146 T ES 17768146T ES 17768146 T ES17768146 T ES 17768146T ES 2906329 T3 ES2906329 T3 ES 2906329T3
Authority
ES
Spain
Prior art keywords
test compound
expression
casp1
dlk1
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17768146T
Other languages
English (en)
Spanish (es)
Inventor
Hervé Groux
Françoise Cottrez
Nathalie Alepee
Virginie Leblanc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUNOSEARCH
Original Assignee
IMMUNOSEARCH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUNOSEARCH filed Critical IMMUNOSEARCH
Application granted granted Critical
Publication of ES2906329T3 publication Critical patent/ES2906329T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES17768146T 2016-09-19 2017-09-19 Método de evaluación del potencial de irritación ocular de productos químicos Active ES2906329T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1658746A FR3056227B1 (fr) 2016-09-19 2016-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques
PCT/EP2017/073675 WO2018050927A1 (fr) 2016-09-19 2017-09-19 Methode d'evaluation du potentiel d'irritation oculaire de produits chimiques

Publications (1)

Publication Number Publication Date
ES2906329T3 true ES2906329T3 (es) 2022-04-18

Family

ID=57583238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17768146T Active ES2906329T3 (es) 2016-09-19 2017-09-19 Método de evaluación del potencial de irritación ocular de productos químicos

Country Status (9)

Country Link
US (1) US12410472B2 (https=)
EP (1) EP3516070B1 (https=)
JP (1) JP7030795B2 (https=)
DK (1) DK3516070T3 (https=)
ES (1) ES2906329T3 (https=)
FR (1) FR3056227B1 (https=)
HU (1) HUE057698T2 (https=)
PL (1) PL3516070T3 (https=)
WO (1) WO2018050927A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
CA2318641A1 (en) * 1998-01-23 1999-07-29 University Of Ottawa Artificial cornea
FR2957090A1 (fr) * 2010-03-05 2011-09-09 Immunosearch Methode d'evaluation du potentiel irritant d'un compose test

Also Published As

Publication number Publication date
JP7030795B2 (ja) 2022-03-07
HUE057698T2 (hu) 2022-05-28
FR3056227B1 (fr) 2021-01-01
FR3056227A1 (fr) 2018-03-23
EP3516070A1 (fr) 2019-07-31
DK3516070T3 (da) 2022-02-14
WO2018050927A1 (fr) 2018-03-22
CA3037091A1 (fr) 2018-03-22
US20190300952A1 (en) 2019-10-03
US12410472B2 (en) 2025-09-09
EP3516070B1 (fr) 2021-12-15
PL3516070T3 (pl) 2022-03-28
JP2019537428A (ja) 2019-12-26

Similar Documents

Publication Publication Date Title
Wienke et al. Galectin‐9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multicohort validation
Doolittle et al. Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton
Ross et al. Transcriptional profiling of mucociliary differentiation in human airway epithelial cells
Saito et al. Distinct expression patterns of alveolar “alarmins” in subtypes of chronic lung allograft dysfunction
Nemeth et al. Fetal membrane distention: II. Differentially expressed genes regulated by acute distention in vitro
AU2022202220A1 (en) Treatment and detection of melanoma
KR20110005708A (ko) 심장 동종이식 급성 거부반응 진단방법
Liu et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis
Okamato et al. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes
Rajakumar et al. Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells
ES2400490T3 (es) Método para el diagnóstico y pronóstico de tolerancia en transplante de hígado empleando tejido hepático
ES2827241T3 (es) Estado de metilación del ADN como un biomarcador del consumo y la abstinencia del alcohol
CN108152357A (zh) 基于唾液蛋白质组学的肝癌脾虚证生物标志物检测的方法
CN107460241A (zh) 外泌体小分子rna在急性心肌梗死风险评估中的应用
ES2906329T3 (es) Método de evaluación del potencial de irritación ocular de productos químicos
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
Desoubeaux et al. Labeled quantitative mass spectrometry to study the host response during aspergillosis in the common bottlenose dolphin (Tursiops truncatus)
Rudzki et al. Toxoplasma gondii GRA28 is required for specific induction of the regulatory chemokine CCL22 in human and mouse cells
US20240182984A1 (en) Methods for assessing proliferation and anti-folate therapeutic response
KR101754490B1 (ko) 천식 진단용 마커 조성물, 이를 포함하는 천식 진단용 키트 및 천식 진단을 위한 정보제공방법
Shevchenko et al. Upregulated circulating mir-424 and its’ diagnostic value for gram-negative bacteremia after thoracic transplantation
KR102242285B1 (ko) 중간엽줄기세포의 전신홍반루푸스 치료효과 예측용 바이오마커 조성물
Ohta et al. Gene expression of leucine-rich alpha-2 glycoprotein in the polypoid lesion of inflammatory colorectal polyps in miniature dachshunds
RU2699792C1 (ru) Способ прогнозирования выживаемости больных светлоклеточным почечно-клеточным раком
KR20180044153A (ko) 바이오마커 마이크로rna-144를 이용한 결핵 진단용 조성물